Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19

Authors : Mirren Charnley, Saba Islam,  Guneet K. Bindra,  Jeremy Engwirda,  Julian Ratcliffe,  Jiangtao Zhou,  Raffaele Mezzenga,  Mark D. Hulett,  Kyunghoon Han,  Joshua T. Berryman & Nicholas P. Reynolds  Nature Communications volume 13, Article number: 3387 (2022)  July…[...]

Read More

Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before

Authors: Jocelyn Solis-Moreira JUNE 20, 2022 https://www.braintomorrow.com/ People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California…[...]

Read More